Testosterone Deficiency Promotes Hypercholesteremia and Attenuates Cholesterol Liver Uptake via AR/PCSK9/LDLR

Yu Yuefeng1, Lin Zhiqi1, Chen Yi1

  • 1Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China.

Abstract

Insights

Testosterone deficiency impairs liver cholesterol uptake by increasing PCSK9 and decreasing LDLR via the androgen receptor pathway. This clarifies a key mechanism linking low testosterone to cholesterol metabolism.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Molecular Biology

Background:

  • Testosterone deficiency is linked to elevated plasma cholesterol, but the underlying mechanisms are not fully understood.
  • Investigating the impact of testosterone on cholesterol metabolism is crucial for understanding cardiovascular health.
  • This study aims to elucidate the molecular changes associated with testosterone deficiency and cholesterol metabolism.

Purpose of the Study:

  • To investigate the effects of testosterone deficiency on cholesterol metabolism in vivo and in vitro.
  • To identify the molecular mechanisms, including key protein changes, involved in altered cholesterol uptake.
  • To determine the role of the androgen receptor and testosterone/DHT in regulating liver cholesterol uptake.

Main Methods:

  • Utilized Sprague-Dawley rats subjected to sham-operation, subtotal orchiectomy, or orchiectomy.
  • Employed HepG2 cells cultured with varying concentrations of testosterone for in vitro analysis.
  • Applied isotope tracing and fluorescence labeling techniques to study cholesterol metabolism and analyzed key molecular regulators.

Main Results:

  • Testosterone deficiency in rats (SO and ORX groups) led to impaired liver cholesterol uptake.
  • In vitro, HepG2 cells showed reduced cholesterol uptake when exposed to low or excessive testosterone levels.
  • Lack of testosterone increased proprotein convertase subtilisin/kexin type 9 (PCSK9) and decreased low-density lipoprotein receptor (LDLR) expression.

Conclusions:

  • Testosterone deficiency attenuates liver cholesterol uptake through the PCSK9-LDLR pathway.
  • The androgen receptor (AR) acts as a mediator in this process.
  • Testosterone, rather than dihydrotestosterone (DHT), is the primary functional androgen form influencing this pathway.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
709
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
905
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
48
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
304
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.1K